VivaanGupta17/glucocast

Glucocast is a very early-stage (2 days old, 0 stars) personal project applying the Temporal Fusion Transformer (TFT) architecture to CGM data. While the use of TFT for glucose prediction is a valid research direction, the project currently lacks any evidence of a dataset, unique IP, or community validation. The problem of CGM prediction is a 'holy grail' in med-tech, currently being pursued by well-funded incumbents like Abbott, Dexcom, and Medtronic, as well as health platforms like Apple and Google (via Verily). These incumbents have access to massive, proprietary, regulated clinical datasets which form the true moat in this space. An open-source implementation of a standard transformer architecture without a unique data advantage or regulatory clearance provides zero defensibility. Furthermore, established open-source diabetes ecosystems like Nightscout and Tidepool already possess the 'data gravity' and integration surface that this project lacks. The displacement risk is high because the hardware manufacturers themselves are increasingly integrating these predictive capabilities directly into their proprietary sensor apps.